New recurrent UTI guideline: What urologists need to know
The AUA/CUA/SUFU guide focuses on a combination of symptoms and positive cultures.
Related Articles
Yair Lotan, MD, on potential future applications of AI in urology
“I think that there will probably be much more accessible tools within the next 5 years, and almost certainly within the next 10 years,” says…
NSD1/2 may serve as potential therapeutic targets in prostate cancer
“NSD2 is a cancer specific collaborator of the androgen receptor that essentially rewires its activity to support prostate cancer development,” says Abhijit Parolia, PhD,
Dr. A. Lenore Ackerman on antibiotic stewardship in managing UTIs
“It’s really upon us, as the medical community, to be better about not just antibiotic stewardship, but also diagnostic stewardship,” says A. Lenore Ackerman, MD,…
TLX250-CDx data published in Lancet Oncology as company seeks FDA approval
The ZIRCON trial reported high accuracy of TLX250-CDx in detecting and characterizing ccRCC in patients with indeterminate renal masses.
Emily Sopko, CNP, on her approach to patient education and counseling in urology
“That’s probably the biggest thing that I would say to somebody who’s interested in urology is, do you think you can get on another patient’s…
Pediatric urinary microbiome composition is associated with recurrent UTI
“We hope to learn more about the urinary tract and then be able to correlate predisposition to UTIs or other urological conditions with urobiome composition…
Piflufolastat (18F) enters commercial market in Spain
Piflufolastat (18F) is being produced at 2 Curium facilities in Madrid and 1 in Sevilla.
Data show short-term benefit of certain hormonal treatments for GSM
Data showed that vaginal estrogen, vaginal DHEA, oral ospemifene, and vaginal moisturizers may provide benefit in the management of symptoms related to GSM.
Dr. Thomas Chi on the CVAC System for treating kidney stones
“What we demonstrated was that at 30-day and 90-day interval outcomes, the patients actually had equivalent safety profiles compared to traditional ureteroscopy with basketing,” says…
Live updates from FDA Advisory Committee meeting on oral sulopenem for uUTI
Follow Urology Times’ coverage of the full-day FDA advisory committee meeting regarding Iterum Therapeutics’ new drug application for oral sulopenem for uncomplicated urinary tract infection.